Global Organ Transplant Immunosuppressant Market 2017-2021

This market research study identifies Astellas Pharma, Novartis, Pfizer, and Sanofi as the leading players in the global organ transplant immunosuppressant market. A comprehensive analysis of this market is also presented by the drug class, therapeutic application, and geography.

Organ transplant immunosuppressant market analysis

According to Technavio’s market research report, the global organ transplant immunosuppressant market will grow at a CAGR of close to 4% during the forecast period. One of the key drivers that will propel the growth prospects for the market during the estimated period is the complications associated with organ transplantation. The recipient body recognizes the transplanted organ or tissue as a foreign body and triggers a blood transfusion reaction. This leads to transplant rejection as a response to the recipient's immune system.

Transplant rejections can be of three types, which includes hyperacute rejection, acute rejection, or chronic rejection. This results in the emergence of immunosuppressive therapy, which is used to achieve a successful organ transplant. Cyclosporine is one of the best immunosuppressants and has established a benchmark of successful immunosuppression.

Get A Free Sample 

Organ transplant immunosuppressant market size based on geography

Countries such as the US, Mexico, Canada, Brazil, Argentina, and Colombia are contributing to the growth of the global organ transplant immunosuppressant market. The availability of developed infrastructure and the rising number of transplantation procedures will boost the application of organ transplant immunosuppressants in the Americas from 2017 to 2021.

Organ transplant immunosuppressant market worth: Competitive landscape and key vendors

The global organ transplant immunosuppressant market is highly concentrated due to the presence of many small and large vendors. These vendors highly focus on offering branded and generic immunosuppressive therapies to expand their customer base. To retain their market shares, vendors are trying to develop enhanced immunosuppressants.

Key vendors in the organ transplant immunosuppressant market

• Astellas Pharma
• Novartis
• Pfizer
• Sanofi

Organ transplant immunosuppressant market by drug class

• Selective inhibitor of cytokine production and function
• Immunosuppressive antimetabolites
• Immunosuppressive antibodies
• Immunosuppressive adrenocorticosteroids

The selective inhibitor of cytokine production and function drug class accounted for the majority market share during 2016. The conventional immunosuppressive therapy involves the application of selective inhibitors of cytokine production and function and antimetabolites such as MMF. However, this may result in late acute rejection episodes and graft losses. Consequently, the application of tacrolimus formulation along with a selective inhibitor of cytokine helps to overcome this problem. The continual dependence of surgeons on the selective inhibitor of cytokine drug class will drive the segment’s growth for the next four years.

Organ transplant immunosuppressant market by therapeutic application 

• Kidney transplantation
• Liver transplantation
• Heart transplantation
• Lung transplantation
• Pancreas transplantation

The kidney transplant immunosuppressant accounted for the maximum market shares during 2016. The sales volume of kidney transplant immunosuppressants will continue to increase in the forthcoming years due to the rising private-public funding for the development of human leukocyte antigen (HLA) typing technology and solid organ-based transplantation.

Want a bigger picture? Try a FREE sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.   

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global organ transplant immunosuppressant market?
• What are the key market trends impacting the growth of the global organ transplant immunosuppressant market?
• What are the challenges to market growth?
• Who are the key vendors in the global organ transplant immunosuppressant market?
• What are the market opportunities and threats faced by the vendors in the global organ transplant immunosuppressant market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global organ transplant immunosuppressant market?

Technavio also offers customization on reports based on specific client requirement.